Medtronic (NYSE:MDT) announced today that the FDA approved its Vanta recharge-free implantable neurostimulator (INS). Fridley, Minn.–based Medtronic touts the Vanta INS as having a device life of up to 11 years — more than twice the device life of competitive primary cell devices, according to a news release. Additionally, Vanta uses Medtronic’s proprietary AdaptiveStim technology […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
NeuroMetrix reports mixed results in fibromyalgia trial
NeuroMetrix (NSDQ:NURO) announced a mixed bag of top-line results from its trial of Quell in patients with fibromyalgia. Woburn, Mass.–based NeuroMetrix’s double-blind, randomized, sham-controlled trial evaluated the treatment of fibromyalgia with Quell, an over-the-counter novel transcutaneous electrical nerve stimulator (TENS) indicated for symptomatic relief and management of chronic lower extremity pain. Quell, a wearable device […]
Meet the drugs and devices giving hope to millions of migraine patients
Up until recently, neurologists had relatively few tools at their disposal to help migraine patients. The treatment landscape for migraines has evolved considerably in recent years, according to Alexander Feoktistov, a neurologist at the Synergy Integrative Headache Center in Chicago. “I’ve been in this field of headache medicine for probably over 20 years now, and […]
FDA approves Medtronic’s SenSight directional lead system for DBS therapy
Medtronic (NYSE:MDT) announced today that it received FDA approval for its SenSight directional lead system used in deep brain stimulation therapy. Fridley, Minn.–based Medtronic designed the SenSight directional lead system for DBS therapy to combine directionality and sensing to allow physicians to deliver precise, patient-specific DBS therapy for treating some symptoms associated with movement disorders […]
Medtronic implant found better at predicting AFib than external device
A Medtronic implant was three times better than an external monitor at detecting new atrial fibrillation in stroke patients, a new study says. The Post-Embolic Rhythm Detection With Implantable Versus External Monitoring (PER DIEM) study pitted Medtronic’s Reveal Linq implantable device, which monitors for AFib over 12 months, against the Spiderflash-T external device made by […]
Noveome Biotherapeutics inks licensing deal for SipNose drug delivery device
Noveome Biotherapeutics announced that it entered a commercial license agreement to use SipNose’s proprietary drug delivery device. Yokneam, Israel–based SipNose develops its intranasal Cribriform Targeted Device (CT6), which, under the agreement, was licensed to Noveome to deliver the Pittsburgh-based company’s ST266 biologic to the central nervous systems, according to a news release. Get the full story at our […]
Medtronic beats The Street in Q4, Hugo robot wins IDE
Medtronic (NYSE:MDT) had much to tout with its pipeline as it released Street-beating fourth-quarter results. CEO Geoff Martha announced to analysts that FDA has granted the company’s much-anticipated Hugo robot an investigational device exemption approval. Medtronic is preparing to commence its Expand Uro trial in the U.S. to study Hugo in urologic procedures, Martha said […]
NeuroOne gains Nasdaq listing
NeuroOne Medical Technologies (OTC:NMTC) announced that it was approved to uplist and begin trading on the Nasdaq market. Eden Prairie, Minn.-based NeuroOne expects trading to commence today at the open of the market, with the company trading under the “NMTC” ticker, according to a news release. The developer of surgical care options for patients suffering […]
Neurosign launches new intraoperative nerve monitor to preserve nerves
Neurosign today announced the U.S. launch of its V4 system for monitoring cranial nerves and spinal nerve roots during surgeries. FDA cleared the V4 4-channel and 8-channel nerve monitoring system in March. “We have many years of experience listening to surgeons and developing systems that solve challenges. The V4 is the next iteration of advanced […]
7 digital health startups you need to watch in 2021
Digital health has skyrocketed in recent years. The pandemic has only propelled its growth by keeping patients away from doctors’ offices in droves. Thanks to the continued adoption of smartphones, the growth of connected medical devices and changes in patients’ and providers’ preferences, digital health will only continue to expand through the 2020s and beyond, […]
FDA leapfrogs guidance on brain-computer interface devices
The FDA today issued leapfrog guidance for nonclinical testing and study design related to implanted brain-computer interface (BCI) devices. Leapfrog guidance allows the agency to share its initial thoughts on emerging technologies that are early in development but appear likely to be of importance to public health, according to a Federal Register notice. The guidance offered […]